Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing Access Your Profit Alerts

Pain Therapeutics (NASDAQ: PTIE)

$3.98 USD $0.06 (1.53%)
Last Price $3.98
Net Change $0.06 (1.53%)
Bid $0.34
Ask Price $4
Open Price $3.99
Previous Close Price $3.92
High Price $4
Low Price $3.94
Number of Trades 49
Volume 19,800
Fifty Two Week High $21 (2016-09-20)
Fifty Two Week Low $3.57 (2016-11-04)
Average Daily Volume 131,631
Share Outstanding 6,590 Shares
Total Dividend Payout 0/yr
Dividend Yield 0%
1st Quarter Earnings $ ()
2nd Quarter Earnings $ ()
3nd Quarter Earnings $ ()
4th Quarter Earnings $ ()
PE Ratio $0
EPS Growth $-21.21
Recent Earnings $
Annual EPS $-1.89
Last Quarter EPS $
Market Capitalization $0.03B
Insider Shareholders % 0.327%
Annual Revenue $0B
No. Shares Outstanding 6,590
Inst. Shareholder % 0%
Annual Net Income $-0.01B
TTM Net Profit Margin $0
1-Year Return -75.28%
3-Year Return -88.47%
5-Year Return -80.29%
5-Year Revenue Growth -100%
5-Year Earnings Growth 450%
5-Year Dividend Growth 0%
Annual Dividend $0
Annual Dividend Yield 0%
Change in EPS YTD -21.209999%
Dividends per Share $0.75
Stock Split Ratio 1-7
Beta 2.22
Pain Therapeutics is developing a new generation of opioid painkillers.Opioids are drugs derived from the poppy plant. The company uses technology to reformulate opioid drugs, such as morphine, into new painkillers with improved clinical benefits. The company has four opioid painkillers in Phase II clinical trials. The company believes its drugs offer enhanced pain relief, fewer adverse side effects and reduced tolerance and addiction compared to existing opioid painkillers.

PTIE News & Stock Updates